Multiomics Services Market Report 2025

The multiomics services market size has grown exponentially in recent years. It will grow from $1.18 billion in 2024 to $1.42 billion in 2025 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to the increasing availability of next-generation sequencing platforms, rising adoption of bioinformatics tools in research, growing demand for biomarker discovery, expanding academic collaborations in systems biology, and the rising application of multiomics in plant science.

The multiomics services market size is expected to see exponential growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to the increasing adoption of sustainable agriculture practices, rising focus on single-cell multiomics, expanding use of spatial omics in disease research, growing demand for personalized nutrition, and the increasing number of clinical trials utilizing multiomics. Major trends in the forecast period include advancements in spatial transcriptomics tools, development of microfluidics-enabled omics workflows, creation of real-time multiomics monitoring systems, innovation in cross-species multiomics applications, and the emergence of wearable omics diagnostic technologies.

The growing adoption of personalized medicine is expected to drive expansion in the multiomics services market in the coming years. Personalized medicine is a healthcare model that uses information about an individual’s genes and lifestyle to tailor treatments and medical care to their specific needs. Its increasing adoption is driven by people’s preference for health technologies that provide real-time monitoring and treatment plans customized to their unique biology. Multiomics services facilitate personalized medicine by integrating various biological data, including genomics, transcriptomics, proteomics, and metabolomics, to deliver a comprehensive understanding of an individual’s health profile. This enables tailored diagnosis, treatment, and disease prevention strategies. For example, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all newly approved therapies, reflecting a notable increase from prior years. Consequently, the rising adoption of personalized medicine is driving growth in the multiomics services market.

Key players in the multiomics services market are developing innovative approaches, such as 3D genome mapping, to enhance understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping involves determining the three-dimensional spatial organization of the genome within a cell’s nucleus. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, launched a suite of 3D multi-omics solutions to accelerate and improve drug discovery precision. The platform integrates genome-wide regulatory interaction data with multi-omics profiles in a single assay, providing comprehensive insights into gene regulation. Its proprietary Promoter Capture Hi-C technology enables precise mapping of long-range interactions between regulatory elements and target genes, including non-coding regions. The modular platform comprising GenLinkConnect, GenLinkResponse, and GenLinkProfile, supports SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Additionally, GenLinkHub software offers an intuitive interface for 3D visualization, data management, and quality control, helping researchers interpret complex datasets and accelerate drug discovery.

In June 2025, Bruker Corporation, a US-based scientific instruments and analytical solutions company, acquired Biocrates Life Sciences AG for an undisclosed amount. Through this acquisition, Bruker aims to strengthen its multiomics strategy by incorporating Biocrates’ advanced metabolomics and lipidomics technologies with its existing proteomics workflows. Biocrates Life Sciences AG, based in Austria, specializes in multiomics services.

Major players in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., and Clinical Microbiomics A/S.

North America was the largest region in the multiomics services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in multiomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the multiomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Multiomics services represent an integrated approach in biological research that combines multiple omics data types, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This method enables comprehensive analysis across different biological layers, providing deeper insights into complex biological systems.

The primary types of multiomics services include single-cell multiomics and bulk multiomics. Single-cell multiomics involves the simultaneous analysis of multiple molecular data types such as genomics, transcriptomics, proteomics, and epigenomics at the resolution of individual cells. These services are applied in areas like biomarker discovery, drug discovery and development, and synthetic biology, and serve a range of end users including academic and research institutions, pharmaceutical and biotechnology companies, and others.

The multiomics services market research report is one of a series of new reports that provides multiomics services market statistics, including multiomics services industry global market size, regional shares, competitors with a multiomics services market share, multiomics services market segments, market trends and opportunities, and any further data you may need to thrive in the multiomics services industry. This multiomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiomics services market includes revenues earned by entities by providing services such as genomics analysis, transcriptomics profiling, proteomics services, metabolomics analysis, and epigenomics studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.